Researchers at Innovative Genomics have developed a CRISPR-based technique that selectively targets and destroys cancer cells, including those resistant to conventional drugs. The gene-editing approach identifies cancerous cells and dismantles them while preserving healthy tissue, potentially expanding treatment options for previously untreatable cancers.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton